Forte Biosciences, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
FBRX Company Description
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
FBRX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view FBRX Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of FBRX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by FBRX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of FBRX in WallStreetBets Daily Discussion
FBRX News
Recent insights relating to FBRX
CNBC Recommendations
Recent picks made for FBRX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in FBRX
Corporate Flights
Flights by private jets registered to FBRX
Our Analysis